Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Beginning Cash Balance (2019 - 2021)

Marimed (MRMD) has disclosed Beginning Cash Balance for 3 consecutive years, with $185.0 as the latest value for Q2 2021.

  • On a quarterly basis, Beginning Cash Balance rose 100.1% to $185.0 in Q2 2021 year-over-year; TTM through Sep 2021 was $1.3 million, a 93.69% decrease, with the full-year FY2019 number at $20.8 million, changed N/A from a year prior.
  • Beginning Cash Balance was $185.0 for Q2 2021 at Marimed, down from $1.2 million in the prior quarter.
  • In the past five years, Beginning Cash Balance ranged from a high of $20.6 million in Q4 2019 to a low of -$177143.0 in Q2 2020.
  • A 3-year average of $3.7 million and a median of $199424.0 in 2020 define the central range for Beginning Cash Balance.
  • Biggest YoY gain for Beginning Cash Balance was 381.33% in 2021; the steepest drop was 100.1% in 2021.
  • Marimed's Beginning Cash Balance stood at $20.6 million in 2019, then tumbled by 99.23% to $158301.0 in 2020, then plummeted by 99.88% to $185.0 in 2021.
  • Per Business Quant, the three most recent readings for MRMD's Beginning Cash Balance are $185.0 (Q2 2021), $1.2 million (Q1 2021), and $158301.0 (Q3 2020).